Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
LifeMD Inc (NASDAQ: LFMD) closed the day trading at $3.49 up 2.35% from the previous closing price of $3.41. In other words, the price has increased by $2.35 from its previous closing price. On the day, 0.88 million shares were traded. LFMD stock price reached its highest trading level at $3.56 during the session, while it also had its lowest trading level at $3.3834.
Ratios:
For a better understanding of LFMD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.01. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 0.73. In the meantime, Its Debt-to-Equity ratio is 4.98 whereas as Long-Term Debt/Eq ratio is at 4.47.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on June 18, 2025, Reiterated its Buy rating but revised its target price to $18 from $15 previously.
On December 10, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.Mizuho initiated its Neutral rating on December 04, 2024, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 09 ’25 when FRIEDEMAN JESSICA sold 15,000 shares for $3.61 per share. The transaction valued at 54,158 led to the insider holds 205,000 shares of the business.
FRIEDEMAN JESSICA bought 20,000 shares of LFMD for $80,800 on Nov 24 ’25. On Sep 10 ’25, another insider, Alvarez Nicholas P, who serves as the Chief Acquisition Officer of the company, sold 75,000 shares for $5.92 each. As a result, the insider received 443,760 and left with 605,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 167994240 and an Enterprise Value of 152787584. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67 while its Price-to-Book (P/B) ratio in mrq is 123.71. Its current Enterprise Value per Revenue stands at 0.611 whereas that against EBITDA is -112.153.
Stock Price History:
The Beta on a monthly basis for LFMD is 1.45, which has changed by -0.39619374 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $15.84, while it has fallen to a 52-week low of $3.18. The 50-Day Moving Average of the stock is -19.49%, while the 200-Day Moving Average is calculated to be -52.83%.
Shares Statistics:
Over the past 3-months, LFMD traded about 1.24M shares per day on average, while over the past 10 days, LFMD traded about 1319460 shares per day. A total of 46.58M shares are outstanding, with a floating share count of 39.43M. Insiders hold about 18.09% of the company’s shares, while institutions hold 42.88% stake in the company. Shares short for LFMD as of 1765756800 were 5046812 with a Short Ratio of 4.06, compared to 1763078400 on 4389291. Therefore, it implies a Short% of Shares Outstanding of 5046812 and a Short% of Float of 12.560001000000002.
Earnings Estimates
The stock of LifeMD Inc (LFMD) is currently drawing attention from 2.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $0.03, with high estimates of $0.12 and low estimates of -$0.07.
Analysts are recommending an EPS of between $0.42 and -$0.23 for the fiscal current year, implying an average EPS of $0.09. EPS for the following year is $0.14, with 2.0 analysts recommending between $0.55 and -$0.26.
Revenue Estimates
8 analysts predict $48.57M in revenue for. The current quarter. It ranges from a high estimate of $58M to a low estimate of $45M. As of. The current estimate, LifeMD Inc’s year-ago sales were $64.25MFor the next quarter, 8 analysts are estimating revenue of $50.07M. There is a high estimate of $58.75M for the next quarter, whereas the lowest estimate is $47.1M.
A total of 8 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $246.1M, while the lowest revenue estimate was $233.09M, resulting in an average revenue estimate of $236.72M. In the same quarter a year ago, actual revenue was $212.45MBased on 8 analysts’ estimates, the company’s revenue will be $224.04M in the next fiscal year. The high estimate is $249.2M and the low estimate is $197M.
